|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
ÇѸ鿡 ¡®EC 35'°¡ »õ°ÜÁø ³ë¶õ»öÀÇ Å¸¿øÇü Çʸ§ÄÚÆÃÁ¤ |
|
|
|
|
|
Á¦Á¶È¸»ç |
Sanofi-Aventis
|
ÆǸÅȸ»ç |
(ÁÖ)»ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ
|
Çã°¡Á¤º¸ |
Á¤»ó
(2012.05.31)
|
BIT ¾àÈ¿ºÐ·ù |
°ñ´ë»ç°ü·Ã¾à¹°(Drugs related to bone metabolism)
|
º¹ÁöºÎºÐ·ù |
399[µû·Î ºÐ·ùµÇÁö ¾Ê´Â ´ë»ç¼º ÀǾàÇ° ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
652104500 Àú°¡¾à ´ëü Àμ¾Æ¼ºê Áö±Þ ´ë»ó \0 ¿ø/1Á¤(2023.03.01)(ÇöÀç¾à°¡)\5,065 ¿ø/1Á¤(2020.01.01) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
Risedronic acid / M05BA07 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]
|
÷°¡Á¦ |
±ÔÈ ¹Ì°áÁ¤¼¿·ê·Î¿À½º,
¸ÞŸ¾ÆÅ©¸±»ê¤ý¾ÆÅ©¸±»ê¿¡Æ¿°øÁßÇÕü(1:1)ºÐ»ê¾×30%,
»êÈö,
½ºÅ׾Ƹ£»ê,
½ºÅ׾Ƹ£»ê¸¶±×³×½·,
½Ã¸ÞƼÄÜ,
½ÃÆ®¸£»êÆ®¸®¿¡Æ¿,
¿¡µ¥Æ®»ê³ªÆ®·ý,
ÀüºÐ±Û¸®Äݻ곪Ʈ·ý(AÇü),
ÅÅÅ©,
Æú¸®¼Ò¸£º£ÀÌÆ®80
|